HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination - Tiezzi, Daniel G.; Andrade, Jurandyr Moreira de; Ribeiro-Silva, Alfredo; Zola, Fábio E.; Marana, Heitor R. C.; Tiezzi, Marcelo G. (BMC Cancer, 2007)